| Primary |
| Rheumatoid Arthritis |
25.0% |
| Seropositive Ra |
25.0% |
| Cardiac Failure |
12.5% |
| Cardiovascular Disorder |
12.5% |
| Chronic Obstructive Pulmonary Disease |
12.5% |
| Psoriatic Arthritis |
12.5% |
|
| Concomitant Disease Progression |
50.0% |
| Tuberculous Pleurisy |
50.0% |
|
| Secondary |
| Non-hodgkin's Lymphoma |
14.0% |
| Hodgkin's Disease |
11.6% |
| Product Used For Unknown Indication |
10.9% |
| Peripheral T-cell Lymphoma Unspecified |
9.9% |
| Rheumatoid Arthritis |
6.5% |
| Multiple Myeloma |
6.1% |
| T-cell Lymphoma |
5.5% |
| Drug Use For Unknown Indication |
4.1% |
| Prophylaxis |
3.8% |
| B-cell Lymphoma |
3.4% |
| Plasma Cell Myeloma |
3.4% |
| Pain |
3.1% |
| Interstitial Lung Disease |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| B-cell Small Lymphocytic Lymphoma |
2.4% |
| Renal Transplant |
2.4% |
| Leukaemia |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Hiv Infection |
1.7% |
| Hypertension |
1.7% |
|
| Sepsis |
10.0% |
| Thrombocytopenia |
10.0% |
| Diabetes Mellitus |
7.5% |
| Peripheral Sensory Neuropathy |
7.5% |
| Rotator Cuff Syndrome |
7.5% |
| Gastric Haemorrhage |
5.0% |
| Hyponatraemia |
5.0% |
| Musculoskeletal Disorder |
5.0% |
| Oesophageal Candidiasis |
5.0% |
| Parkinson's Disease |
5.0% |
| Social Avoidant Behaviour |
5.0% |
| Tuberculous Pleurisy |
5.0% |
| Vomiting |
5.0% |
| Abdominal Discomfort |
2.5% |
| Concomitant Disease Progression |
2.5% |
| Gastric Ulcer |
2.5% |
| General Physical Health Deterioration |
2.5% |
| Haematemesis |
2.5% |
| Haemolytic Anaemia |
2.5% |
| Headache |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.2% |
| Product Used For Unknown Indication |
17.0% |
| Rheumatoid Arthritis |
16.7% |
| Renal Transplant |
5.4% |
| Osteoporosis |
5.2% |
| Multiple Myeloma |
4.1% |
| Crohn's Disease |
3.3% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Hypertension |
3.2% |
| Prophylaxis |
3.1% |
| Drug Exposure During Pregnancy |
2.4% |
| Pain |
2.3% |
| Prostate Cancer |
1.8% |
| Arthritis |
1.7% |
| Hiv Infection |
1.7% |
| Renal Cell Carcinoma |
1.5% |
| Systemic Lupus Erythematosus |
1.5% |
| Colon Cancer |
1.4% |
| Asthma |
1.1% |
| Juvenile Idiopathic Arthritis |
1.1% |
|
| Pneumonia |
8.2% |
| Weight Decreased |
7.4% |
| Dyspnoea |
6.6% |
| Lung Infection |
6.6% |
| Thrombocytopenia |
6.6% |
| Pulmonary Tuberculosis |
5.7% |
| Renal Failure |
5.7% |
| Unevaluable Event |
5.7% |
| Pain |
4.9% |
| Pain In Extremity |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Pulmonary Embolism |
4.1% |
| Sepsis |
4.1% |
| Therapeutic Response Decreased |
4.1% |
| Tuberculosis |
4.1% |
| Urinary Tract Infection |
4.1% |
| Death |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Nausea |
3.3% |
| Premature Baby |
3.3% |
|
| Interacting |
| Nephrotic Syndrome |
33.3% |
| Renal Transplant |
33.3% |
| Sleep Disorder |
33.3% |
|
| Drug Interaction |
66.7% |
| Renal Cell Carcinoma |
33.3% |
|
